Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis

Author:

Huang Fujiao1,Liu Fangyan1,Zhen Xiaofang1,Gong Shu2,Chen Wenbi1,Song Zhangyong134ORCID

Affiliation:

1. School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China

2. The Public Platform of Cell Biotechnology, Public Center of Experimental Technology, Southwest Medical University, Luzhou 646000, China

3. Molecular Biotechnology Platform, Public Center of Experimental Technology, Southwest Medical University, Luzhou 646000, China

4. Hemodynamics and Medical Engineering Combination Key Laboratory of Luzhou, Luzhou 646000, China

Abstract

Rhinosinusitis is a common inflammatory disease of the sinonasal mucosa and paranasal sinuses. The pathogenesis of rhinosinusitis involves a variety of factors, including genetics, nasal microbiota status, infection, and environmental influences. Pathogenic microorganisms, including viruses, bacteria, and fungi, have been proven to target the cilia and/or epithelial cells of ciliated airways, which results in the impairment of mucociliary clearance, leading to epithelial cell apoptosis and the loss of epithelial barrier integrity and immune dysregulation, thereby facilitating infection. However, the mechanisms employed by pathogenic microorganisms in rhinosinusitis remain unclear. Therefore, this review describes the types of common pathogenic microorganisms that cause rhinosinusitis, including human rhinovirus, respiratory syncytial virus, Staphylococcus aureus, Pseudomonas aeruginosa, Aspergillus species, etc. The damage of mucosal cilium clearance and epithelial barrier caused by surface proteins or secreted virulence factors are summarized in detail. In addition, the specific inflammatory response, mainly Type 1 immune responses (Th1) and Type 2 immune responses (Th2), induced by the entry of pathogens into the body is discussed. The conventional treatment of infectious sinusitis and emerging treatment methods including nanotechnology are also discussed in order to improve the current understanding of the types of microorganisms that cause rhinosinusitis and to help effectively select surgical and/or therapeutic interventions for precise and personalized treatment.

Funder

the Technology Strategic Cooperation Project of Luzhou Municipal People’s Government-Southwest Medical University

the Foundation of Southwest Medical University

the open project of Chongqing Key Laboratory of Microsporidia Infection and Control

Publisher

MDPI AG

Reference240 articles.

1. European position paper on rhinosinusitis and nasal polyps 2020;Fokkens;Rhinology,2020

2. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists;Fokkens;Rhinology,2012

3. Tocilizumab-induced hypofibrinogenemia: A report of 7 cases;Martis;Jt. Bone Spine,2017

4. Clinical practice guideline (update): Adult sinusitis;Rosenfeld;Otolaryngol. Head Neck Surg.,2015

5. National burden of antibiotic use for adult rhinosinusitis;Smith;J. Allergy Clin. Immunol.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3